Northumberland-based drug maker SCM Pharma has acquired a new facility as part of a collaborative deal with the University of Sunderland to support the launch of a new service.
Online PR News – 01-January-2012 – – Northumberland-based drug maker SCM Pharma has acquired a new facility as part of a collaborative deal with the University of Sunderland to support the launch of a new service.
The development and contract manufacturing organisation (CDMO), which specialises in making sterile drug products, will house its new formulation development capability in laboratory space within the university’s state-of-the-art £8.5m science complex.
SCM Pharma’s formulation service is one that naturally complements its established clinical trial product supplyoffering at its manufacturing HQ in Prudhoe. The move follows a two year development project with Mitovie Pharma to assist the speciality drug developer with formulation support.
The award-winning North-East manufacturer will use major upcoming pharmaceutical trade events in Germany and the USA as the global platforms to showcase its new in-house service offerings.
Dianne Sharp, managing director at SCM Pharma, said: “We are delighted to be teaming up with the University of Sunderland to help widen our service offering and support our continued expansion.
“This is a huge milestone for our business and what better stages than the international events in October to simultaneously launch this core new service to the European and North American markets.
“Although we have seen huge export growth over the last two years, we are now working with most of the universities in the region, which emphasises how committed and firmly rooted we are in the North-East. We expect this deal to demonstrate how local partnerships established right on our doorstep can impact global markets.”
To coincide with the acquisition, SCM Pharma has recruited pharmacist Ian Davis as a Senior Technologist to work within the new facility. Ian will support the launch and operate as a scientist assisting the company’s technical team. A graduate from the University of Sunderland himself, Ian has worked at Bristol Myers Squibb and AstraZeneca but is relocating back to the North-East.
Ian will work within a dedicated department that includes several experienced formulation scientists, which has been set-up to support pharmaceutical companies, hospitals and universities needing to formulate or reformulate novel new medicines.
Dr Adrian Moore, team leader for Pharmaceutical Science at the University of Sunderland, said: “Linking up with SCM Pharma in our Sciences Complex is an incredibly exciting opportunity for our scientific staff, students and researchers on campus and is a reflection of our significant experience in the area of pharmaceutics.
“We have state-of-the-art analytical equipment on site that SCM Pharma can access, which will help support the rapid development of their new products, as well as exposure to a team of specialists with expertise in pharmaceutics.
“Working in conjunction with a leading North East SME also greatly enhances our student experience as our students will be able to interact with people in the pharmaceutical industry and see first-hand pharmaceutical practices in operation.
“We are also delighted to be welcoming back on campus Ian Davis and Neal Wesley, from SCM Pharma, who are both former graduates of this university.”
SCM Pharma, http://www.scmpharma.com ,now helps clients formulate new medicines in addition to supplying them with finished product for clinical trials and commercial markets. It is able to fill liquids, gels and powders into a range of presentations including vials, ampoules, syringes, bottles and cartridges.
With around 80 employees, it has now worked across a number of therapeutic areas including cancer, diabetes, arthritis, epilepsy, dermatitis, needle-free injection technology and sexual health.